Ribonucleotide triggered DNA damage and RNA-DNA damage responses

RNA Biology

Volumn 11, Issue 11, 2014, Pages 1340-1346

  Wallace, Bret D ^a   Williams, R Scott ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

2 3 cyclic PO4; Abortive ligation; Acardi Goutieres syndrome; AOA1; Aprataxin; Aptx; Ataxia oculomotor apraxia; DNA adenylation; DNA damage; DNA ligase; DNA repair; Flap Endonuclease 1 (FEN 1); Genome stability; Ribonucleotide Excision Repair (RER); RNA DNA damage; RNase H2; Top1cc; Top2cc; Topoisomerase 1 (Top1); Topoisomerase 2 (Top2); Tyrosyl DNA phosphodiesterase 2 (Tdp2)

Indexed keywords

DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); GENOMIC DNA; RIBONUCLEOTIDE; APTX PROTEIN, HUMAN; DNA; DNA BINDING PROTEIN; NUCLEAR PROTEIN; PROTEIN BINDING; RNA;

CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DNA REPLICATION; DNA RESPONSIVE ELEMENT; EXCISION REPAIR; GENOMIC INSTABILITY; MOLECULAR BIOLOGY; MUTAGENESIS; NONHUMAN; POLYMERIZATION; REVIEW; ANIMAL; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DNA REPAIR; GENETICS; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ANIMALS; DNA; DNA DAMAGE; DNA REPAIR; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; HUMANS; MODELS, GENETIC; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NUCLEAR PROTEINS; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEOTIDES; RNA;

EID: 84923576997     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/15476286.2014.992283     Document Type: Review

References (57)

1. Crick F. Central dogma of molecular biology. Nature 1970; 227:561-3; PMID:4913914; http://dx.doi.org/ 10.1038/227561a0
2. Nick McElhinny SA, Watts BE, Kumar D, Watt DL, Lundstrom EB, Burgers PM, Johansson E, Chabes A, Kunkel TA. Abundant ribonucleotide incorporation into DNA by yeast replicative polymerases. Proc Natl Acad Sci U S A 2010; 107:4949-54; PMID:20194773; http://dx.doi.org/10.1073/pnas.0914857107
3. McDonald JP, Vaisman A, Kuban W, Goodman MF, Woodgate R. Mechanisms employed by Escherichia coli to prevent ribonucleotide incorporation into genomic DNA by Pol V. PLoS Genetics 2012; 8:e1003030; PMID:23144626; http://dx.doi.org/10.1371/journal. pgen.1003030
4. Shen Y, Koh KD, Weiss B, Storici F. Mispaired rNMPs in DNA are mutagenic and are targets of mismatch repair and RNases H. Nat Struct Mol Biol 2012; 19:98-104; http://dx.doi.org/10.1038/nsmb.2176
5. Miyabe I, Kunkel TA, Carr AM. The major roles of DNA polymerases epsilon and delta at the eukaryotic replication fork are evolutionarily conserved. PLoS Genetics 2011; 7:e1002407; PMID:22144917; http:// dx.doi.org/10.1371/journal.pgen.1002407
6. Williams JS, Smith DJ, Marjavaara L, Lujan SA, Chabes A, Kunkel TA. Topoisomerase 1-mediated removal of ribonucleotides from nascent leading-strand DNA. Mol Cell 2013; 49:1010-5; PMID:23375499; http://dx.doi.org/10.1016/j.molcel.2012.12.021
7. Nick McElhinny SA, Kumar D, Clark AB, Watt DL, Watts BE, Lundstrom EB, Johansson E, Chabes A, Kunkel TA. Genome instability due to ribonucleotide incorporation into DNA. Nat Chem Biol 2010; 6:774-81; PMID:20729855; http://dx.doi.org/10.1038/ nchembio.424
8. Reijns MA, Rabe B, Rigby RE, Mill P, Astell KR, Lettice LA, Boyle S, Leitch A, Keighren M, Kilanowski F, et al. Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 2012; 149:1008-22; PMID:22579044; http://dx.doi.org/10.1016/j.cell.2012.04.011
9. Hiller B, Achleitner M, Glage S, Naumann R, Behrendt R, Roers A. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J Exp Med 2012; 209:1419-26; PMID:22802351; http://dx.doi.org/10.1084/jem.20120876
10. Nick McElhinny SA, Ramsden DA. Polymerase mu is a DNA-directed DNA/RNA polymerase. Mol Cell Biol 2003; 23:2309-15; PMID:12640116; http://dx.doi. org/10.1128/MCB.23.7.2309-2315.2003
11. Kasiviswanathan R, Copeland WC. Ribonucleotide discrimination and reverse transcription by the human mitochondrial DNA polymerase. J Biol Chem 2011; 286:31490-500; PMID:21778232; http://dx.doi.org/ 10.1074/jbc.M111.252460
12. Sparks JL, Chon H, Cerritelli SM, Kunkel TA, Johansson E, Crouch RJ, Burgers PM. RNase H2-initiated ribonucleotide excision repair. Mol Cell 2012; 47:980-6; PMID:22864116; http://dx.doi.org/10.1016/j. molcel.2012.06.035
13. Rydberg B, Game J. Excision of misincorporated ribonucleotides in DNA by RNase H (type 2) and FEN-1 in cell-free extracts. Proc Natl Acad Sci U S A 2002; 99:16654-9; PMID:12475934; http://dx.doi.org/ 10.1073/pnas.262591699
14. Chen JZ, Qiu J, Shen B, Holmquist GP. Mutational spectrum analysis of RNase H(35) deficient Saccharomyces cerevisiae using fluorescence-based directed termination PCR. Nucleic Acids Res 2000; 28:3649-56; PMID:10982888; http://dx.doi.org/10.1093/nar/ 28.18.3649
15. Kim N, Huang SN,Williams JS, Li YC, Clark AB, Cho JE, Kunkel TA, Pommier Y, Jinks-Robertson S. Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science 2011; 332:1561-4; PMID:21700875; http://dx.doi.org/10.1126/science. 1205016
16. Rychlik MP, Chon H, Cerritelli SM, Klimek P, Crouch RJ, Nowotny M. Crystal structures of RNase H2 in complex with nucleic acid reveal the mechanism of RNA-DNA junction recognition and cleavage. Mol Cell 2010; 40:658-70; PMID:21095591; http://dx.doi. org/10.1016/j.molcel.2010.11.001
17. Chapados BR, Chai Q, Hosfield DJ, Qiu J, Shen B, Tainer JA. Structural biochemistry of a type 2 RNase H: RNA primer recognition and removal during DNA replication. J Mol Biol 2001; 307:541-56; PMID:11254381; http://dx.doi.org/10.1006/jmbi.2001.4494
18. Chon H, Sparks JL, Rychlik M, Nowotny M, Burgers PM, Crouch RJ, Cerritelli SM. RNase H2 roles in genome integrity revealed by unlinking its activities. Nucleic Acids Res 2013; 41:3130-43; PMID:23355612; http://dx.doi.org/10.1093/nar/gkt027
19. Li Y, Breaker RR. Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2'-Hydroxyl group. J Am Chem Soc 1999; 121:5364-72; http://dx.doi.org/10.1021/ja990592p
20. Ban C, Ramakrishnan B, Sundaralingam M. A single 2'-hydroxyl group converts B-DNA to A-DNA. Crystal structure of the DNA-RNA chimeric decamer duplex d (CCGGC)r(G)d(CCGG) with a novel intermolecular G-C base-paired quadruplet. J Mol Biol 1994; 236:275-85; PMID:7508984; http://dx.doi.org/ 10.1006/jmbi.1994.1134
21. DeRose EF, Perera L, Murray MS, Kunkel TA, London RE. Solution structure of the Dickerson DNA dodecamer containing a single ribonucleotide. Biochemistry 2012; 51:2407-16; PMID:22390730; http://dx.doi. org/10.1021/bi201710q
22. Chiu HC, Koh KD, Evich M, Lesiak AL, Germann MW, Bongiorno A, Riedo E, Storici F. RNA intrusions change DNA elastic properties and structure. Nanoscale 2014; 6:10009-17; PMID:24992674; http://dx.doi. org/10.1039/C4NR01794C
23. Rumbaugh JA, Murante RS, Shi S, Bambara RA. Creation and removal of embedded ribonucleotides in chromosomal DNA during mammalian Okazaki fragment processing. J Biol Chem 1997; 272:22591-9; PMID:9278414; http://dx.doi.org/10.1074/jbc.272.36. 22591
24. Pascal JM, O'Brien PJ, Tomkinson AE, Ellenberger T. Human DNA ligase I completely encircles and partially unwinds nicked DNA. Nature 2004; 432:473-8; PMID:15565146; http://dx.doi.org/10.1038/nature 03082
25. Tumbale P, Williams JS, Schellenberg MJ, Kunkel TA, Williams RS. Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity. Nature 2014; 506:111-5; PMID:24362567; http://dx.doi.org/ 10.1038/nature12824
26. Sekiguchi J, Shuman S. Site-specific ribonuclease activity of eukaryotic DNA topoisomerase I. Mol Cell 1997; 1:89-97; PMID:9659906; http://dx.doi.org/10.1016/ S1097-2765(00)80010-6
27. Wang Y, Knudsen BR, Bjergbaek L, Westergaard O, Andersen AH. Stimulated activity of human topoisomerases IIalpha and IIbeta on RNA-containing substrates. J Biol Chem 1999; 274:22839-46; PMID:10428869; http://dx.doi.org/10.1074/jbc.274.32. 22839
28. Gao R, Schellenberg MJ, Huang SY, Abdelmalak M, Marchand C, Nitiss KC, Nitiss JL, Williams RS, Pommier Y. Proteolytic Degradation of Topoisomerase II (Top2) Enables the Processing of Top2.DNA and Top2.RNA Covalent Complexes by Tyrosyl-DNAPhosphodiesterase 2 (TDP2). J Biol Chem 2014; 289:17960-9; PMID:24808172; http://dx.doi.org/ 10.1074/jbc.M114.565374
29. Pommier Y, Huang SY, Gao R, Das BB, Murai J, Marchand C. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair 2014; 19:114-29; PMID:24856239; http://dx.doi.org/10.1016/j.dnarep. 2014.03.020
30. Pommier Y. Drugging topoisomerases: lessons and challenges. ACS Chem Biol 2013; 8:82-95; PMID:23259582; http://dx.doi.org/10.1021/cb300648v
31. Cho JE, Kim N, Li YC, Jinks-Robertson S. Two distinct mechanisms of Topoisomerase 1-dependent mutagenesis in yeast. DNA Repair 2013; 12:205-11; PMID:23305949; http://dx.doi.org/10.1016/j.dnarep. 2012.12.004
32. Redinbo MR, Stewart L, Kuhn P, Champoux JJ, Hol WG. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 1998; 279:1504-13; PMID:9488644; http://dx. doi.org/10.1126/science.279.5356.1504
33. Potenski CJ, Niu H, Sung P, Klein HL. Avoidance of ribo-nucleotide-induced mutations by RNase H2 and Srs2-Exo1 mechanisms. Nature 2014; 511:251-4; PMID:24896181; http://dx.doi.org/10.1038/nature13292
34. Nitiss JL. DNA topoisomerase II and its growing repertoire of biological functions. Nat Rev Cancer 2009; 9:327-37; PMID:19377505; http://dx.doi.org/ 10.1038/nrc2608
35. Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009; 9:338-50; PMID:19377506; http://dx.doi.org/10.1038/nrc2607
36. Gomez-Herreros F, Romero-Granados R, Zeng Z, Alvarez-Quilon A, Quintero C, Ju L, Umans L, Vermeire L, Huylebroeck D, Caldecott KW, et al. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo. PLoS Genetics 2013; 9:e1003226; PMID:23505375; http://dx.doi. org/10.1371/journal.pgen.1003226
37. Zeng Z, Cortes-Ledesma F, El Khamisy SF, Caldecott KW. TDP2/TTRAP is the major 50 -tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-inducedDNA damage. J Biol Chem 2011; 286:403-9; PMID:21030584; http://dx.doi.org/10.1074/jbc.M110.181016
38. Cortes Ledesma F, El Khamisy SF, Zuma MC, Osborn K, Caldecott KW. A human 50 -tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 2009; 461:674-8; PMID:19794497; http://dx.doi.org/10.1038/nature08444
39. Virgen-Slane R, Rozovics JM, Fitzgerald KD, Ngo T, Chou W, van der Heden van Noort GJ, Filippov DV, Gershon PD, Semler BL. An RNA virus hijacks an incognito function of a DNA repair enzyme. Proc Natl Acad Sci U S A 2012; 109:14634-9; PMID:22908287; http://dx.doi.org/10.1073/pnas.1208096109
40. Schellenberg MJ, Appel CD, Adhikari S, Robertson PD, Ramsden DA, Williams RS. Mechanism of repair of 5'-topoisomerase II-DNA adducts by mammalian tyrosyl-DNA phosphodiesterase 2. Nat Struct Mol Biol 2012; 19:1363-71; PMID:23104055; http://dx.doi. org/10.1038/nsmb.2418
41. Shi K, Kurahashi K, Gao R, Tsutakawa SE, Tainer JA, Pommier Y, Aihara H. Structural basis for recognition of 5'-phosphotyrosine adducts by Tdp2. Nat Struct Mol Biol 2012; 19:1372-7; PMID:23104058; http:// dx.doi.org/10.1038/nsmb.2423
42. Ahel I, Rass U, El-Khamisy SF, Katyal S, Clements PM, McKinnon PJ, Caldecott KW, West SC. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature 2006; 443:713-6; PMID:16964241; http://dx.doi.org/ 10.1038/nature05164
43. Tumbale P, Appel CD, Kraehenbuehl R, Robertson PD, Williams JS, Krahn J, Ahel I, Williams RS. Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease. Nat Struct Mol Biol 2011; 18:1189-95; PMID:21984210; http://dx.doi. org/10.1038/nsmb.2146
44. Harris JL, Jakob B, Taucher-Scholz G, Dianov GL, Becherel OJ, Lavin MF. Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage. Hum Mol Genet 2009; 18:4102-17; PMID:19643912; http://dx.doi.org/10.1093/hmg/ ddp359
45. Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, Igarashi S, Koike R, Hiroi T, Yuasa T, Awaya Y, et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet 2001; 29:184-8; PMID:11586299; http://dx.doi.org/10.1038/ng1001-184
46. Crow YJ, Leitch A, Hayward BE, Garner A, Parmar R, Griffith E, Ali M, Semple C, Aicardi J, Babul-Hirji R, et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genetics 2006; 38:910-6; PMID:16845400; http://dx.doi.org/ 10.1038/ng1842
47. Reijns MA, Jackson AP. Ribonuclease H2 in health and disease. Biochem Soc Trans 2014; 42:717-25; PMID:25109948; http://dx.doi.org/10.1042/ BST20140079
48. Gomez-Herreros F, Schuurs-Hoeijmakers JH, McCormack M, Greally MT, Rulten S, Romero-Granados R, Counihan TJ, Chaila E, Conroy J, Ennis S, et al. TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function. Nat Genetics 2014; 46:516-21; PMID:24658003; http://dx.doi.org/10.1038/ng.2929
49. Vengrova S, Dalgaard JZ. The wild-type Schizosaccharomyces pombe mat1 imprint consists of two ribonucleotides. EMBO Reports 2006; 7:59-65; PMID:16299470; http://dx.doi.org/10.1038/sj.embor. 7400576
50. Vengrova S, Dalgaard JZ. RNase-sensitive DNA modification (s) initiates S. pombe mating-type switching. Genes Deve 2004; 18:794-804; PMID:15059961; http://dx.doi.org/10.1101/gad.289404
51. Lujan SA, Williams JS, Clausen AR, Clark AB, Kunkel TA. Ribonucleotides are signals for mismatch repair of leading-strand replication errors. Mol Cell 2013; 50:437-43; PMID:23603118; http://dx.doi.org/ 10.1016/j.molcel.2013.03.017
52. Ghodgaonkar MM, Lazzaro F, Olivera-Pimentel M, Artola-Boran M, Cejka P, Reijns MA, Jackson AP, Plevani P, Muzi-Falconi M, Jiricny J. Ribonucleotides misincorporated into DNA act as strand-discrimination signals in eukaryotic mismatch repair. Mol Cell 2013; 50:323-32; PMID:23603115; http://dx.doi.org/ 10.1016/j.molcel.2013.03.019
53. Setlow RB. DNA repair, aging, and cancer. Natl Cancer Inst Monogr 1982; 60:249-55; PMID:7121571
54. Hoeijmakers JH. DNA damage, aging, and cancer. New Engl J Med 2009; 361:1475-85; PMID:19812404; http://dx.doi.org/10.1056/NEJMra0804615
55. Nakamura J, Mutlu E, Sharma V, Collins L, Bodnar W, Yu R, Lai Y, Moeller B, Lu K, Swenberg J. The endogenous exposome. DNA Repair 2014; 19:3-13; PMID:24767943; http://dx.doi.org/10.1016/j.dnarep. 2014.03.031
56. Tsutakawa SE, Classen S, Chapados BR, Arvai AS, Finger LD, Guenther G, Tomlinson CG, Thompson P, Sarker AH, Shen B, et al. Human flap endonuclease structures, DNA double-base flipping, and a unified understanding of the FEN1 superfamily. Cell 2011; 145:198-211; PMID:21496641; http://dx.doi.org/ 10.1016/j.cell.2011.03.004
57. Tsutakawa SE, Lafrance-Vanasse J, Tainer JA. The cutting edges in DNA repair, licensing, and fidelity: DNA and RNA repair nucleases sculpt DNA to measure twice, cut once. DNA Repair 2014; 19:95-107; PMID:24754999; http://dx.doi.org/10.1016/j.dnarep. 2014.03.022